Literature DB >> 24172328

Anticancer drugs: IDH2 drives cancer in vivo.

Isabel Lokody1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24172328     DOI： 10.1038/nrd4160

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Induction of sarcomas by mutant IDH2.

Authors:  Chao Lu; Sriram Venneti; Altuna Akalin; Fang Fang; Patrick S Ward; Raymond G Dematteo; Andrew M Intlekofer; Chong Chen; Jiangbin Ye; Meera Hameed; Khedoudja Nafa; Narasimhan P Agaram; Justin R Cross; Raya Khanin; Christopher E Mason; John H Healey; Scott W Lowe; Gary K Schwartz; Ari Melnick; Craig B Thompson
Journal:  Genes Dev       Date:  2013-09-15       Impact factor: 11.361

2.  Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.

Authors:  Chong Chen; Yu Liu; Chao Lu; Justin R Cross; John P Morris; Aditya S Shroff; Patrick S Ward; James E Bradner; Craig Thompson; Scott W Lowe
Journal:  Genes Dev       Date:  2013-09-15       Impact factor: 11.361
  2 in total
  1 in total

Review 1.  The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.